Details

Alibio

Founding year:

2018

full-time-employees:

1

Funding state:

0-100k

Alibio generates value by bringing managerial, fund-raising and marketing capacity to the commercialization of early stage research. Alibio will manage the development of biotechnology-related intellectual property from university labs into clinical testing. We focus on in-licensing promising research from universities and developing Preclinical/Phase 1/ Phase 2 trials over a 5-7 year time horizon. We will manage research and manufacturing capabilities through outsourcing vendors in order to reduce costs and ramp-up times.

Industry

Technology Focus

Company Type

Users